The Relative Contributions of HAART and Alpha-interferon for Therapy of Progressive Multifocal Leukoencephalopathy in AIDS

Overview

Journal J Neurovirol

Publisher Springer

Specialties Microbiology
Neurology

Date 2001 Aug 23

PMID 11517416

Citations 27

Authors

M D Geschwind

R I Skolasky

W S Royal

J C McArthur

Affiliations

Soon will be listed here.

Abstract

To explore the respective roles of highly active antiretroviral therapy (HAART) and alpha-interferon in improving survival of patients with AIDS-related PML, we retrospectively analyzed all patients with AIDS and PML who were referred to Johns Hopkins University HIV Neurology Program from 1985 to 2000. For 97 evaluable patients, we compared survival of those who were on HAART (three or more antiretroviral drugs) to those who were not on HAART. The effect of alpha-interferon was also studied. Multivariate analysis showed no difference in survival among patients on none, one, or two forms of antiretrovirals; however, survival was significantly greater for those on HAART. Whereas alpha-interferon use was shown to be associated with longer survival (P < 0.057), this effect was not independent of the effects of HAART. HAART significantly increases survival for patients with PML and AIDS; however, alpha-interferon does not appear to provide additional benefit.

Citing Articles

Long-term prognosis and overall mortality in patients with progressive multifocal leukoencephalopathy.

Kim J, Kim C, Lee J, Lee S, Lee K, Kim J Sci Rep. 2023; 13(1):14291.

PMID: 37652945 PMC: 10471597. DOI: 10.1038/s41598-023-41147-9.

Progressive Multifocal Leukoencephalopathy in HIV-Uninfected Individuals.

Saylor D, Venkatesan A Curr Infect Dis Rep. 2016; 18(11):33.

PMID: 27686675 DOI: 10.1007/s11908-016-0543-8.

Progressive multifocal leukoencephalopathy therapy.

Clifford D J Neurovirol. 2014; 21(6):632-6.

PMID: 25227934 PMC: 4363307. DOI: 10.1007/s13365-014-0289-8.

Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the....

Siberry G, Abzug M, Nachman S, Brady M, Dominguez K, Handelsman E Pediatr Infect Dis J. 2014; 32 Suppl 2:i-KK4.

PMID: 24569199 PMC: 4169043. DOI: 10.1097/01.inf.0000437856.09540.11.

Immune surveillance and response to JC virus infection and PML.

Beltrami S, Gordon J J Neurovirol. 2013; 20(2):137-49.

PMID: 24297501 PMC: 3972311. DOI: 10.1007/s13365-013-0222-6.

References

Happe S, Besselmann M, Matheja P, Rickert C, Schuierer G, Reichelt D . [Cidofovir (vistide) in therapy of progressive multifocal leukoencephalopathy in AIDS. Review of the literature and report of 2 cases]. Nervenarzt. 1999; 70(10):935-43. DOI: 10.1007/s001150050601. View

Giudici B, Vaz B, Bossolasco S, Casari S, Brambilla A, Luke W . Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response. Clin Infect Dis. 2000; 30(1):95-9. DOI: 10.1086/313598. View

Cinque P, Casari S, Bertelli D . Progressive multifocal leukoencephalopathy, HIV, and highly active antiretroviral therapy. N Engl J Med. 1998; 339(12):848-9. DOI: 10.1056/NEJM199809173391216. View

Tassie J, Gasnault J, Bentata M, Deloumeaux J, Boue F, Billaud E . Survival improvement of AIDS-related progressive multifocal leukoencephalopathy in the era of protease inhibitors. Clinical Epidemiology Group. French Hospital Database on HIV. AIDS. 1999; 13(14):1881-7. DOI: 10.1097/00002030-199910010-00010. View

Berger J, Major E . Progressive multifocal leukoencephalopathy. Semin Neurol. 2000; 19(2):193-200. DOI: 10.1055/s-2008-1040837. View

De Luca A, Ammassari A, Cingolani A, Giancola M, Antinori A . Disease progression and poor survival of AIDS-associated progressive multifocal leukoencephalopathy despite highly active antiretroviral therapy. AIDS. 1998; 12(14):1937-8. View

Clifford D, Yiannoutsos C, GLICKSMAN M, Simpson D, Singer E, Piliero P . HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology. 1999; 52(3):623-5. DOI: 10.1212/wnl.52.3.623. View

Tantisiriwat W, Tebas P, Clifford D, Powderly W, Fichtenbaum C . Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy. Clin Infect Dis. 1999; 28(5):1152-4. DOI: 10.1086/514762. View

HALL C, Dafni U, Simpson D, Clifford D, Wetherill P, Cohen B . Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team. N Engl J Med. 1998; 338(19):1345-51. DOI: 10.1056/NEJM199805073381903. View

10.

Happe S, Lunenborg N, Rickert C, Heese C, Reichelt D, Schuierer G . [Progressive multifocal leukoencephalopathy in AIDS. Overview and retrospective analysis of 17 patients]. Nervenarzt. 2000; 71(2):96-104. DOI: 10.1007/s001150050014. View

11.

De Luca A, Giancola M, Ammassari A, Grisetti S, Paglia M, Gentile M . The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoencephalopathy. J Infect Dis. 2000; 182(4):1077-83. DOI: 10.1086/315817. View

12.

Taoufik Y, Delfraissy J, Gasnault J . Highly active antiretroviral therapy does not improve survival of patients with high JC virus load in the cerebrospinal fluid at progressive multifocal leukoencephalopathy diagnosis. AIDS. 2000; 14(6):758-9. DOI: 10.1097/00002030-200004140-00022. View

13.

Dworkin M, Wan P, Hanson D, Jones J . Progressive multifocal leukoencephalopathy: improved survival of human immunodeficiency virus-infected patients in the protease inhibitor era. J Infect Dis. 1999; 180(3):621-5. DOI: 10.1086/314937. View

14.

Albrecht H, Hoffmann C, Degen O, Stoehr A, Plettenberg A, Mertenskotter T . Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy. AIDS. 1998; 12(10):1149-54. DOI: 10.1097/00002030-199810000-00006. View

15.

Huang S, Skolasky R, Dal Pan G, Royal 3rd W, McArthur J . Survival prolongation in HIV-associated progressive multifocal leukoencephalopathy treated with alpha-interferon: an observational study. J Neurovirol. 1998; 4(3):324-32. DOI: 10.3109/13550289809114533. View

16.

Miralles P, Berenguer J, Garcia de Viedma D, Padilla B, Cosin J, Munoz L . Treatment of AIDS-associated progressive multifocal leukoencephalopathy with highly active antiretroviral therapy. AIDS. 1999; 12(18):2467-72. DOI: 10.1097/00002030-199818000-00016. View